Department of Medicine, University of Valencia/INCLIVA Health Research Institute and CIBERSAM, Valencia, Spain.
Fundación Instituto de Investigación en Servicios de Salud, Valencia, Spain.
Syst Rev. 2017 Jul 11;6(1):137. doi: 10.1186/s13643-017-0540-5.
Anorexia nervosa is characterized by a severe restriction of caloric intake, low body weight, fear of gaining weight or of becoming fat, and disturbance of body image. Pathogenesis of the disorder may include genetic predisposition, hormonal changes and a combination of environmental, psychosocial, and cultural factors. Cancer is the second leading cause of death worldwide. At present, no systematic reviews and meta-analyses have evaluated the risk of cancer in people with anorexia nervosa. The objective of this study will be to evaluate the association between anorexia nervosa and the risk of developing or dying from cancer.
METHODS/DESIGN: This study protocol is part of a systematic collection and assessment of multiple systematic reviews and meta-analyses (umbrella review) evaluating the association of cancer and multiple central nervous system disorders. We designed a specific protocol for a new systematic review and meta-analysis of observational studies of anorexia nervosa with risk of developing or dying from any cancer. Data sources will be PubMed, Embase, Scopus, Web of Science, and manual screening of references. Observational studies (case-control and cohort) in humans that examined the association between anorexia nervosa and risk of developing or dying from cancer will be sought. The primary outcomes will be cancer incidence and cancer mortality in association with anorexia nervosa. Secondary outcomes will be site-specific cancer incidence and mortality, respectively. Screening of abstracts and full texts, and data abstraction will be performed by two team members independently. Conflicts at all levels of screening and abstraction will be resolved through discussion. The quality of studies will be assessed by using the Ottawa-Newcastle scale by two team members independently. Random effects models will be conducted where appropriate. Subgroup and additional analyses will be conducted to explore the potential sources of heterogeneity. The World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) criteria and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach will be used for determining the quality of evidence for cancer outcomes.
Findings from this systematic review will inform an ongoing umbrella review on cancer and central nervous system disorders. Our systematic review and meta-analysis of observational studies will establish the extent of the epidemiological evidence underlying the association between anorexia nervosa and cancer.
PROSPERO CRD42017067462.
神经性厌食症的特征是严重限制热量摄入、体重过低、害怕体重增加或变胖以及对身体形象的扭曲。该疾病的发病机制可能包括遗传易感性、激素变化以及环境、心理社会和文化因素的综合作用。癌症是全球第二大死亡原因。目前,尚无系统评价和荟萃分析评估神经性厌食症患者罹患癌症的风险。本研究的目的将是评估神经性厌食症与罹患或死于癌症的风险之间的关联。
方法/设计:本研究方案是系统收集和评估多个系统性综述和荟萃分析(伞式综述)的一部分,这些综述评估了癌症与多种中枢神经系统疾病之间的关联。我们为一项关于神经性厌食症与罹患或死于任何癌症风险的观察性研究的新系统评价和荟萃分析设计了一个特定的方案。数据来源将包括 PubMed、Embase、Scopus、Web of Science 和手动筛选参考文献。将检索观察性研究(病例对照和队列研究),以评估神经性厌食症与癌症发病或死亡风险之间的关联。主要结局将是与神经性厌食症相关的癌症发病率和癌症死亡率。次要结局将分别为特定部位的癌症发病率和死亡率。两名研究人员将独立进行摘要和全文筛选以及数据提取。在各级筛选和提取中出现的争议将通过讨论解决。两名研究人员将独立使用渥太华-纽卡斯尔量表评估研究质量。在适当的情况下,将使用随机效应模型进行分析。将进行亚组和额外分析,以探索潜在的异质性来源。世界癌症研究基金会(WCRF)/美国癌症研究所(AICR)标准和推荐评估、制定与评价(GRADE)方法将用于确定癌症结局证据的质量。
本系统综述的结果将为正在进行的癌症和中枢神经系统疾病伞式综述提供信息。我们对观察性研究的系统评价和荟萃分析将确定神经性厌食症与癌症之间关联的流行病学证据的程度。
PROSPERO CRD42017067462。